What Happened?
Boston, MA-based Albireo Pharma Appointed Brian DiMarco as Senior Director, Marketing
Date of management change: February 13, 2022
Boston, MA-based Albireo Pharma Appointed Brian DiMarco as Senior Director, Marketing
Albireo Pharma is a clinical-stage biopharmaceutical company focused through its operating subsidiary on the development of novel bile acid modulators to treat orphan pediatric liver diseases, and other liver and gastrointestinal diseases and disorders. Albireo`s lead product candidate, A4250, is directed to treat rare pediatric cholestatic liver diseases and is in Phase 3 development in its initial target indication, progressive familial intrahepatic cholestasis. Albireo`s clinical pipeline also includes two Phase 2 product candidates. Albireo`s elobixibat, approved in Japan for the treatment of chronic constipation, is the first ileal bile acid transporter (IBAT) inhibitor approved anywhere in the world. Albireo was spun out from AstraZeneca in 2008. Albireo Pharma is located in Boston, Massachusetts, and its key operating subsidiary is located in Gothenburg, Sweden.
Brian DiMarco is Senior Director, Marketing at Albireo Pharma. Previously, Brian held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Chavez Wing Cynthia, Ponce Alberto, Martinez Richard, Millay Jennifer, Delavega Maria, Smith Haisley, Froelich Aubrey, Carlson Brad, Ryan Peter, Ter-Karapetyan Nelli, Tasi Irene
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.